Literature DB >> 25318828

Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.

Chun-Cheng Wang, Cheng-Li Lin, Guei-Jane Wang, Chiz-Tzung Chang, Fung-Chang Sung, Chia-Hung Kao1.   

Abstract

Whether atrial fibrillation (AF) is associated with an increased risk of venous thromboembolism (VTE) remains controversial. From Longitudinal Health Insurance Database 2000 (LHID2000), we identified 11,458 patients newly diagnosed with AF. The comparison group comprised 45,637 patients without AF. Both cohorts were followed up to measure the incidence of deep-vein thrombosis (DVT) and pulmonary embolism (PE). Univariable and multivariable competing-risks regression model and Kaplan-Meier analyses with the use of Aelon-Johansen estimator were used to measure the differences of cumulative incidences of DVT and PE, respectively. The overall incidence rates (per 1,000 person-years) of DVT and PE between the AF group and non-AF groups were 2.69 vs 1.12 (crude hazard ratio [HR]= 1.92; 95 % confidence interval [CI] = 1.54-2.39), 1.55 vs 0.46 (crude HR = 2.68; 95 % CI = 1.97-3.64), respectively. The baseline demographics indicated that the members of the AF group demonstrated a significantly older age and higher proportions of comorbidities than non-AF group. After adjusting for age, sex, and comorbidities, the risks of DVT and PE remained significantly elevated in the AF group compared with the non-AF group (adjusted HR = 1.74; 95 %CI = 1.36-2.24, adjusted HR = 2.18; 95 %CI = 1.51-3.15, respectively). The Kaplan-Meier curve with the use of Aelon-Johansen estimator indicated that the cumulative incidences of DVT and PE were both more significantly elevated in the AF group than in the non-AF group after a long-term follow-up period (p<0.01). In conclusion, the presence of AF is associated with increased risk of VTE after a long-term follow-up period.

Entities:  

Keywords:  Atrial fibrillation; deep-vein thrombosis; population-based cohort study; pulmonary embolism; venous thromboembolism

Mesh:

Year:  2014        PMID: 25318828     DOI: 10.1160/TH14-05-0405

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  Can venous thromboembolism navigate the prevention of cardiovascular complications?

Authors:  Alena Shantsila; Gregory Y H Lip
Journal:  Ann Transl Med       Date:  2015-06

Review 2.  Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.

Authors:  Laila Staerk; Jason A Sherer; Darae Ko; Emelia J Benjamin; Robert H Helm
Journal:  Circ Res       Date:  2017-04-28       Impact factor: 17.367

3.  Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study.

Authors:  P L Lutsey; F L Norby; A Alonso; M Cushman; L Y Chen; E D Michos; A R Folsom
Journal:  J Thromb Haemost       Date:  2018-03-13       Impact factor: 5.824

4.  Atrial fibrillation is related to lower incidence of deep venous thrombosis in patients with pulmonary embolism.

Authors:  Khalid Bin Waleed; Xumin Guan; Xintao Li; Yiheng Yang; Zhao Wang; Xiaomeng Yin; Zhengyan Wang; Jianghai Liu; Lianjun Gao; Dong Chang; Xianjie Xiao; Rongfeng Zhang; Gary Tse; Yunlong Xia
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Advanced chronic kidney disease in non-valvular atrial fibrillation: extending the utility of R2CHADS2 to patients with advanced renal failure.

Authors:  Josef Bautista; Archie Bella; Ashok Chaudhari; Gerald Pekler; Katherine J Sapra; Roger Carbajal; Donald Baumstein
Journal:  Clin Kidney J       Date:  2015-02-16

6.  Hormone replacement therapy and risk of atrial fibrillation in Taiwanese menopause women: A nationwide cohort study.

Authors:  Wei-Chung Tsai; Yaw-Bin Haung; Hsuan-Fu Kuo; Wei-Hua Tang; Po-Chao Hsu; Ho-Ming Su; Tsung-Hsien Lin; Chih-Sheng Chu; Shih-Jie Jhuo; Kun-Tai Lee; Sheng-Hsiung Sheu; Chung-Yu Chen; Ming-Tsang Wu; Wen-Ter Lai
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

7.  Atrial Fibrillation is Associated With Morphine Treatment in Female Breast Cancer Patients: A Retrospective Population-Based Time-Dependent Cohort Study.

Authors:  Cynthia Wei-Sheng Lee; Chih-Hsin Muo; Ji-An Liang; Ming-Chia Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

8.  End-stage renal disease: a risk factor of deep neck infection - a nationwide follow-up study in Taiwan.

Authors:  Geng-He Chang; Ming-Shao Tsai; Chia-Yen Liu; Meng-Hung Lin; Yao-Te Tsai; Cheng-Ming Hsu; Yao-Hsu Yang
Journal:  BMC Infect Dis       Date:  2017-06-13       Impact factor: 3.090

9.  Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients.

Authors:  Pamela L Lutsey; Faye L Norby; Neil A Zakai; Richard F MacLehose; Lin Y Chen; Surbhi Shah; Yvonne H Datta; Alvaro Alonso
Journal:  Curr Med Res Opin       Date:  2018-12-03       Impact factor: 2.580

10.  Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

Authors:  Erin M Hald; Ludvig B Rinde; Maja-Lisa Løchen; Ellisiv B Mathiesen; Tom Wilsgaard; Inger Njølstad; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  J Am Heart Assoc       Date:  2018-01-29       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.